Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nutra Pharma, a biotechnology company marketing Nyloxin and Pet Pain-Away in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced that they have engaged Pickwick Capital Partners; a leading investment banking, securities and investment management firm, to provide strategic corporate planning and investment banking services.
Subscribe to our email newsletter
Pickwick will focus on assisting Nutra Pharma in its strategies for maximizing shareholder value through its full scope of investment banking services.
"Nutra Pharma is in the process of managing growth as we expand the market for our OTC products," commented Rik J Deitsch, Chief Executive Officer of Nutra Pharma.
"We recently announced our expansion into India and China. As our sales increase and the Company matures, we need strategic advisors to help navigate these waters, provide sound financial counseling and maximize the potential benefits to our customers and shareholders," he continued.
"We are pleased to have retained a leading investment banking firm to assist the company with these important strategic decisions," he concluded.
Pickwick Capital Partners, LLC is a FINRA-Registered Broker Dealer and a Member of SIPC. They act as Strategic Advisors and Investment Bankers for a variety of corporate clients. In these capacities, they offer a full range of Business Development services and a complete array of transactional services for emerging and middle market corporate clients.
Pickwick is also active in the placement of alternative asset Funds with institutional and accredited Investors.
"Pickwick Capital Partners is dedicated to creating real economic value for all of our clients and their stakeholders; investors, shareholders, management, and employees," stated Doug Greenwood, Chief Executive Officer of Pickwick Capital Partners.
"We constantly seek to understand the objectives and needs of our clients, to provide superior services to them, and to earn their trust, respect, and confidence," he continued. "We are happy to be working with Nutra Pharma and helping them achieve their goals as they continue to grow," he concluded.